Last updated 2026-06-18
- Raised $30M funding round, Sep 2025
- Raised $30M funding round, Oct 2022
- Raised $6.7M funding round led by Mölnlycke Health Care, Jul 2024
Total raised
$198.7M
Last: 2025-09
Stage
Public
Founded
2000
Headcount
121
HQ
Yavne, Israel
Sector
Health Tech & Life Sciences
About
MediWound is a global biotechnology company pioneering enzymatic, non-surgical therapies for tissue repair. The company’s FDA-approved biologic, NexoBrid, is indicated for the enzymatic removal of eschar in thermal burns and is marketed in the United States, European Union, Japan, and additional international markets. MediWound’s late-stage pipeline product, EscharEx, is an investigational therapy for the debridement of chronic wounds, with potential to become a new standard of care in wound management.
Funding history · 6 rounds · $198.7M total
2025-09
$30.0M
2024-07
2022-10
2013-06
Q&A
- What is MediWound's primary focus?
- MediWound is a global biotechnology company specializing in enzymatic, non-surgical therapies for tissue repair, with a focus on thermal burns and chronic wounds.
- What is MediWound's key FDA-approved product?
- MediWound's FDA-approved biologic, NexoBrid, is indicated for the enzymatic removal of eschar in thermal burns and is available in the United States, European Union, Japan, and other international markets.
- What is MediWound's investigational product for chronic wounds?
- MediWound's late-stage pipeline product, EscharEx, is an investigational therapy for the debridement of chronic wounds.
- When was MediWound founded?
- MediWound was founded in January 2000.
- How many employees does MediWound have?
- MediWound has 51–200 employees.
- What was MediWound's most recent funding round?
- In September 2025, MediWound completed a funding round of $30,000,000.
- Which investors participated in MediWound's July 2024 funding round?
- In July 2024, MediWound raised $6,690,000 with Mölnlycke Health Care as a lead investor.
- What is MediWound's current market capitalization?
- MediWound's market capitalization is $236,683,653.
- Where is MediWound's headquarters located?
- MediWound's headquarters is located in Yavne, Israel.
Team · 3
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticals
Business model
B2B2C
Highlights
1 Patents
Tags
tissue-regenerationdermatologyburnsbiotechnologytopical-treatmentpatientspharma-companiespharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | mediwound.com |
|---|---|
| linkedin.com/company/1644054 | |
| facebook.com/pages/Mediwound/457872115038886 | |
| YouTube | youtube.com/user/MediWound |
| Wikidata | wikidata.org/wiki/Q43896231 |
Identifiers & details
| Founded | 2000-1 |
|---|---|
| Employees (exact) | 121 |
| Offices | Wilmington; Rüsselsheim |
| Market cap | $236.7M |
| Status reason | Public on NASDAQ on Mar, 2014; |
| Wikidata QID | Q43896231 |
Radar intelligence
Patents
| EPO | 14 |
|---|
Publications (Crossref)
| Works | 4 |
|---|
Web history (Wayback)
| Domain | mediwound.com |
|---|
Wikidata
| QID | Q43896231 |
|---|